| Patent Number |
Title Of Patent |
Date Issued |
| 6808719 |
Drug delivery device |
October 26, 2004 |
| Drug delivery devices, and methods of delivering pharmaceutically active agents to a target tissue within a body using such devices, are disclosed. One drug delivery device includes a body having an internal surface for placement proximate a target tissue and a well having an opening to |
| 6669950 |
Ophthalmic drug delivery device |
December 30, 2003 |
| The present invention is directed to a drug delivery device for a human eye. The human eye has a sclera, an inferior oblique muscle, and a macula. The device of the present invention includes a pharmaceutically active agent, and a geometry that facilitates the implantation of the device |
| 6416777 |
Ophthalmic drug delivery device |
July 9, 2002 |
| The present invention is directed to a drug delivery device for a human eye. The human eye has a sclera, an inferior oblique muscle, and a macula. The device of the present invention includes a pharmaceutically active agent, and a geometry that facilitates the implantation of the device |
| 6413540 |
Drug delivery device |
July 2, 2002 |
| Drug delivery devices, and methods of delivering pharmaceutically active agents to a target tissue within a body using such devices, are disclosed. One drug delivery device includes a body having an internal surface for placement proximate a target tissue and a well having an opening to |
| 6413245 |
Sub-tenon drug delivery |
July 2, 2002 |
| Disclosed is a method and apparatus for delivering a drug formulation to a human eye. The method includes the steps of inserting the apparatus below the Tenon's capsule and above the sclera at a point posterior to the limbus of the eye and injecting the drug formulation to form a drug de |
| 5860994 |
Remotely operable intraocular surgical instrument for automated capsulectomies |
January 19, 1999 |
| A remotely operable intraocular surgical instrument specially adapted to perform anterior capsulectomy/capsulorhexis for extracapsular cataract extractions and emulsifications is disclosed. The intraocular instrument has a main body portion including at least two internally defined p |
